Participate Now: New AMA RUC Survey on Physician Office Visits and Prolonged Services

February 26, 2019

ASCO members who are practicing oncologists may have received an email inviting them to participate in the American Medical Association’s (AMA) Specialty Society Relative Value Scale (RVS) Update Committee (RUC) survey for physician office visits (99202-99205, 99211-99215) and a new prolonged services code (99XXX). This important survey will help ASCO, in concert with the RUC, recommend accurate relative values for physician work and direct practice expenses to the Centers for Medicare & Medicaid Services. ASCO members are encouraged to participate if they are invited to take the survey.

A link to the survey, with the new guidelines for office visits, is provided in the email from Please note that the email may be in junk or spam inboxes.

The Current Procedural Terminology (CPT) guidelines and descriptors to report office visit codes will undergo extensive revision for implementation in 2021. Code level selection of office visits will be based on either medical decision making or total time on the date of the visit and will no longer include the extent of history or physical examination. Participants should be sure to read the new CPT guidelines and code descriptors in the email before taking the survey.

The survey will also capture practice expenses, such as nurse time spent related to each code level of the office visits and the typical medical supplies and equipment used in the provision of the visit. Participants should be prepared to work on this part with clinical staff and practice managers.

This survey is very important to ASCO and the medical profession. To ensure integrity of the data, we ask participants not to collaborate with any other physician on responses to the physician work portion of the survey. Please contact Allison Hirschorn at with any questions.

For more information on the RUC survey process, please watch Understanding the RUC Survey Instrument.

Visit ASCO in Action for updates on ASCO’s work with the AMA and the latest cancer policy news.